Harvard Bioscience, Inc. (HBIO)
7.48
0.00 (0.00%)
USD |
NASDAQ |
Aug 24, 16:00
7.34
-0.14
(-1.87%)
After-Hours: 20:00
Harvard Bioscience Enterprise Value : 71.75M for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 71.75M |
| August 20, 2026 | 72.07M |
| August 19, 2026 | 69.93M |
| August 18, 2026 | 69.43M |
| August 17, 2026 | 67.29M |
| August 14, 2026 | 68.00M |
| August 13, 2026 | 68.07M |
| August 12, 2026 | 65.79M |
| August 11, 2026 | 65.61M |
| August 10, 2026 | 66.79M |
| August 07, 2026 | 67.16M |
| August 06, 2026 | 65.88M |
| August 05, 2026 | 66.70M |
| August 04, 2026 | 66.43M |
| August 03, 2026 | 66.43M |
| July 31, 2026 | 65.47M |
| July 30, 2026 | 65.43M |
| July 29, 2026 | 65.56M |
| July 28, 2026 | 64.65M |
| July 27, 2026 | 64.97M |
| July 24, 2026 | 65.02M |
| July 23, 2026 | 65.88M |
| July 22, 2026 | 65.61M |
| July 21, 2026 | 65.20M |
| July 20, 2026 | 65.52M |
| Date | Value |
|---|---|
| July 17, 2026 | 66.06M |
| July 16, 2026 | 64.79M |
| July 15, 2026 | 65.15M |
| July 14, 2026 | 64.70M |
| July 13, 2026 | 65.56M |
| July 10, 2026 | 65.65M |
| July 09, 2026 | 66.06M |
| July 08, 2026 | 66.29M |
| July 07, 2026 | 67.88M |
| July 06, 2026 | 66.61M |
| July 02, 2026 | 65.70M |
| July 01, 2026 | 65.24M |
| June 30, 2026 | 65.70M |
| June 29, 2026 | 64.65M |
| June 26, 2026 | 64.27M |
| June 25, 2026 | 63.90M |
| June 24, 2026 | 64.45M |
| June 23, 2026 | 64.13M |
| June 22, 2026 | 64.33M |
| June 18, 2026 | 63.50M |
| June 17, 2026 | 64.09M |
| June 16, 2026 | 63.86M |
| June 15, 2026 | 64.04M |
| June 12, 2026 | 64.45M |
| June 11, 2026 | 66.97M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agilent Technologies, Inc. | 46.42B |
| Bio-Rad Laboratories, Inc. | 9.912B |
| Bruker Corp. | 10.73B |
| Danaher Corp. | 177.35B |
| Illumina, Inc. | 34.49B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.91M |
| Revenue (Quarterly) | 22.73M |
| Total Expenses (Quarterly) | 25.64M |
| EPS Diluted (Quarterly) | -0.643 |
| Gross Profit Margin (Quarterly) | 51.96% |
| Profit Margin (Quarterly) | -12.80% |
| Earnings Yield | -31.06% |
| Operating Earnings Yield | 1.71% |
| Normalized Earnings Yield | -29.35 |